Integral Diagnostics Ltd. ( (AU:IDX) ) has shared an update.
Integral Diagnostics Ltd. announced a change in the director’s interest, with Raelene Murphy acquiring an additional 15,000 fully paid ordinary shares, bringing her total to 45,945 shares. This transaction, conducted through an on-market trade at $2.36 per share, reflects a strategic move that could influence the company’s governance and stakeholder confidence.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates in the healthcare industry, providing diagnostic imaging services. The company focuses on delivering high-quality radiology services across Australia and New Zealand, utilizing advanced imaging technology to support patient care and medical decision-making.
YTD Price Performance: -18.40%
Average Trading Volume: 1,662,216
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$873.8M
For detailed information about IDX stock, go to TipRanks’ Stock Analysis page.